Search Results (936)

Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline, memory loss, and behavioral changes. It poses a significant global health challenge. AD is associated with the accumulation of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain, along with chronic inflammation, dysfunctional neurons, and synapse loss. While the prevalence of AD continues to rise, the current FDA-approved drugs offer only limited effectiveness. Emerging evidence suggests that obesity, insulin resistance (IR), and type 2 diabetes mellitus (T2DM) are also implicated in AD pathogenesis, with epidemiological studies and animal models confirming the impact of IR on Aβ accumulation, and high-fat diets also exacerbating Aβ accumulation. Since neuroinflammation activated by Aβ involves the nuclear factor kappa-light-chain-enhancer of the activated B cell (NF-κB) pathway, the inhibition of NF-κB and NLRP3 inflammasome activation are potential therapeutic strategies in AD. Bioactive compounds, including polyphenols (resveratrol, epigallocatechin-3-gallate, curcumin, and quercetin), and omega-3 polyunsaturated fatty acids, show promising results in animal studies and clinical trials for reducing Aβ levels, improving cognition and modulating the signaling pathways implicated in AD. This review explores the interplay between obesity, IR, inflammation, and AD pathology, emphasizing the potential of dietary compounds and their role in reducing inflammation, oxidative stress, and cognitive decline, as viable strategies for AD prevention and treatment. By integrating epidemiological findings, observational studies, and clinical trials, this review aims to provide a comprehensive understating of how metabolic dysfunctions and bioactive compounds influence AD progression. Full article

The application of walnut protein isolate (WPI) and polyphenols is usually limited by low solubility. To solve the above problem, the impact of the alkaline treatment method and the ultrasound-assisted alkaline treatment method on the structural and functional properties of protein–polyphenol covalent complexes (WPI–(–)-epigallocatechin-3-gallate (EGCG), UWPI–EGCG, respectively) was explored. Fourier transform infrared spectroscopy and fluorescence spectroscopy indicated that the covalent binding of EGCG to WPI altered the secondary and tertiary structures of the protein and increased its random coil content. In addition, the UWPI–EGCG samples had the lowest particle size (153.67 nm), the largest absolute zeta potential value (25.4 mV), and the highest polyphenol binding (53.37 ± 0.33 mg/g protein). Meanwhile, WPI–EGCG covalent complexes also possessed excellent solubility and emulsification properties. These findings provide a promising approach for WPI in applications such as functional foods. Full article

Atherosclerosis is a persistent inflammatory disorder influenced by oxidative stress and lipid imbalances, and it continues to be a major contributor to cardiovascular diseases. Rich in catechins and flavonoids, green tea pressurized hot water extract (GPHWE) demonstrated potent antioxidant activity through DPPH, ABTS, hydroxyl, and nitric oxide scavenging assays. In vitro, GPHWE protected RAW264.7 macrophages from oxidized LDL (Ox-LDL)-induced cytotoxicity and apoptosis by mitigating oxidative stress and enhancing cell survival. Animal studies using mice fed a high-fat diet (HFD) revealed notable improvements in lipid profiles, including decreases in total cholesterol, LDL, the atherosclerosis index (AI), the coronary risk index (CRI), and triglycerides, as well as lower levels of malondialdehyde (MDA), an indicator of oxidative stress. These results were comparable to those achieved with Simvastatin. Molecular docking studies indicated strong binding affinities of catechins to essential targets such as LOX-1, HMG-CoA reductase, caspase-3, and Nrf2, implying that the mechanisms of GPHWE involve antioxidant properties, regulation of lipids, and stabilization of plaques. The catechins of GPHWE, including epigallocatechin gallate (EGCG), epicatechin gallate (ECG), and epigallocatechin (EGC), were tentatively identified through qualitative analysis performed by UHPLC-QTOF-MS. This comprehensive approach positions GPHWE as a promising natural remedy for preventing atherosclerosis and reducing cardiovascular risk. Full article

A fluorescent cell-based assay was developed for the screening of chemicals repressing the expression of human telomerase reverse transcriptase (hTERT). hTERT is reactivated during carcinogenesis and is overexpressed in more than 90% of cancers but is almost silent in normal tissue cells. Because of its critical role in cancer, hTERT is a target in various therapeutic strategies for cancer treatment. In this study, the hTERT promoter was cloned in MCF7 breast cancer cells and used to control the expression of enhanced green fluorescent protein (EGFP). The fluorescence of EGFP indicated the activity of the hTERT promoter, and, in the presence of an hTERT repressor, the EGFP fluorescence signal was reduced as compared to the EGFP fluorescence controlled by the human cytomegalovirus (CMV) promoter, which was not affected by changes in culture conditions and worked as a control. The EGFP reporter cells were cultivated in three-dimensional (3D) microbioreactors to resemble the in vivo tumor physiology and provide in vivo-like responses. The assay’s predictability was demonstrated with three known hTERT inhibitors, pristimerin, epigallocatechin gallate, and n-butylidenephthalide, and further evaluated with five widely used anticancer compounds, doxorubicin, cisplatin, paclitaxel, blasticidin, and tamoxifen. The results showed overall accuracy of over 83.3%, demonstrating the feasibility of using the hTERT promoter with EGFP as a reporter for the screening of potential cancer drugs targeting hTERT. Full article

Glochidion chodoense, a rare and endangered plant endemic to Republic of Korea, is known for containing a wide variety of phytochemicals, including triterpenoid saponins and flavonoids. This study sought to profile the phytochemical composition of the leaves and branches of G. chodoense harvested during three different periods (May, July, and October 2023) using liquid chromatography–electrospray ionization/mass spectrometry (LC-ESI/MS) and high-performance liquid chromatography–photodiode array detection (HPLC/PDA). Plant materials were harvested, authenticated, and subjected to ethanol extraction prior to chemical analysis. LC-ESI/MS and quantitative HPLC/PDA analyses were conducted to identify and quantify nine key phytochemicals: norbergenin (1), bergenin (2), epigallocatechin (3), ethyl gallate (4), orientin (5), epicatechin gallate (6), isovitexin 2″-O-arabinoside (7), ellagic acid (8), and cynaroside (9). Our findings revealed significant seasonal variations in major phytochemicals, with leaves containing higher concentrations than branches. Notably, bergenin (2) showed the highest content in May leaves (43.42 mg/g extract), followed by October (17.60 mg/g extract) and July branches (8.56 mg/g extract). Ethyl gallate (4), which was absent or present in trace amounts in branches, was abundant in leaves, with concentrations of 22.24 mg/g extract in October, 21.75 mg/g extract in May, and 17.48 mg/g extract in July. A similar trend was observed for norbergenin (1). These findings provide valuable insights into the phytochemical composition of G. chodoense, emphasizing its potential applications in pharmaceuticals, cosmetics, and functional foods, while highlighting the critical importance of conserving this endangered species. Full article

The liver, as the primary metabolic organ, is susceptible to an array of factors that can harm liver cells and give rise to different liver diseases. Epigallocatechin gallate (EGCG), a natural compound found in green tea, exerts numerous beneficial effects on the human body. Notably, EGCG displays antioxidative, antibacterial, antiviral, anti-inflammatory, and anti-tumor properties. This review specifically highlights the pivotal role of EGCG in liver-related diseases, focusing on viral hepatitis, autoimmune hepatitis, fatty liver disease, and hepatocellular carcinoma. EGCG not only inhibits the entry and replication of hepatitis B and C viruses within hepatocytes, but also mitigates hepatocytic damage caused by hepatitis-induced inflammation. Furthermore, EGCG exhibits significant therapeutic potential against hepatocellular carcinoma. Combinatorial use of EGCG and anti-hepatocellular carcinoma drugs enhances the sensitivity of drug-resistant cancer cells to chemotherapeutic agents, leading to improved therapeutic outcomes. Thus, the combination of EGCG and anti-hepatocellular carcinoma drugs holds promise as an effective approach for treating drug-resistant hepatocellular carcinoma. In conclusion, EGCG possesses hepatoprotective properties against various forms of liver damage and emerges as a potential drug candidate for liver diseases. Full article

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder linked to oxidative stress, mitochondrial dysfunction, and neuroinflammation. This study evaluates the neurofunctional and immunomodulatory effects of an aqueous extract combining cocoa seed husk and guarana powder (GuaCa). Eighteen extracts were characterized by flavonoid and polyphenol content, antioxidant activity, and genoprotective potential. The HCE3 extract, rich in catechins, quercetin, and epigallocatechin gallate, was selected for further analysis in three models: Eisenia fetida earthworms, SH-SY5Y neuron-like cells, and peripheral blood mononuclear cells (PBMCs) from PD patients. Results: The extracts showed antioxidant and genoprotective activity and contained flavonoid. No significant toxicity was observed in Eisenia fetida. In SH-SY5Y cells, GuaCa increased cell viability and brain-derived neurotrophic factor (BDNF) levels and reduced mitochondrial damage by lowering extracellular NDUSF7 (subunit of the NADH dehydrogenase (ubiquinone) complex) levels. In dPD-PBMCs cultures, GuaCa reduced pro-inflammatory cytokine IL-6 levels, indicating immunomodulatory effects. Conclusion: GuaCa shows promise as a nutraceutical for managing neuroinflammation and mitochondrial dysfunction in PD. Further clinical studies are needed to confirm GuaCa extract efficacy and potential for neuroprotective dietary strategies. Full article

Green tea (Camellia sinensis) exhibits significant potential in oral health due to its antioxidant, anti-inflammatory, and antimicrobial properties. This review explores its role in managing periodontal disease, a common condition characterized by inflammation, microbial imbalances, and tissue destruction. The primary bioactive components, particularly epigallocatechin-3-gallate (EGCG), contribute to green tea’s therapeutic effects by inhibiting bacterial adhesion, modulating inflammatory pathways, and reducing oxidative stress. Clinical studies suggest green tea improves periodontal health by reducing pocket depth, inflammation, and bleeding. It can serve as an adjunct to conventional therapies, including scaling and root planing, and be incorporated into oral care products such as mouthwashes and dentifrices. Furthermore, green tea presents a natural alternative to chemical agents like chlorhexidine, potentially mitigating side effects and addressing concerns about antibiotic resistance. However, its efficacy remains moderate compared to established treatments, highlighting the need for further research to optimize its formulation and therapeutic applications. Green tea represents a sustainable and biocompatible approach to periodontal therapy, supporting its integration into preventive and therapeutic oral health strategies. Full article

Coffee is a beverage that contains a high concentration of bioactive compounds, particularly polyphenols. These compounds significantly contribute to the polyphenol intake in the diet and have been shown to have beneficial effects on consumer health. The objective of this research was to conduct a comparative analysis of the polyphenolic composition of coffee beans and infusions obtained from coffee beans sourced from both organic and conventional farming practices while taking into consideration variations in roast intensity and geographical origin. The lyophilized coffee grounds and infusions derived from these grounds were also subjected to analysis. The antioxidant activity was measured by using the radical ABTS, and the quantitative and qualitative analysis of polyphenolic compounds was conducted by HPLC. The conventional coffee samples were richer in chlorogenic acid, catechin, and caffeic acid. However, the coffee beans from organic farming contained more gallic acid, epigallocatechin gallate, and quercetin than those grown conventionally. We did not observe significant differences among the coffee plant production sites in Ethiopia, Sumatra, and Peru, but Peru had the poorest amount of polyphenols when compared to Ethiopia and Sumatra. Coffee infusions prepared from organic coffee beans were characterized by a significantly high sum of identified polyphenols. A higher content of caffeine was observed in the organic coffee bean samples than in the conventional coffee bean samples. Conventional coffee beans were characterized by stronger antioxidant activity than organic beans. Coffees from different parts of the world were characterized by different profiles of polyphenol compounds. Moreover, the coffee beans from Ethiopia were characterized by the highest caffeine content. However, among the different geographical areas of coffee beans, the highest antioxidant activity was detected in the coffee beans from Sumatra. Coffee grounds also have the potential to be used as compounds for the cultivation of horticultural plants, and they can be used as a source of numerous health-promoting compounds in the food and cosmetics industries. Full article

Non-alcoholic fatty liver disease (NAFLD) is considered a significant global health issue related to serious metabolic disorders. However, effective pharmacological treatments are still limited. Flavonoids, a wide group of polyphenol substances, exert anti-inflammatory and lipid-lowering effects in preclinical data. Thus, implementing these research findings in clinical practice could significantly help manage NAFLD and its consequences. This narrative review assesses the therapeutic potential of flavonoids in managing NAFLD. The research collected randomized controlled trials (RCTs) and meta-analyses of RCTs from the past five years concerning the impact of flavonoids on NAFLD. A total of 20 studies were selected according to predetermined inclusion criteria, comprising thirteen randomized controlled trials (RCTs) and seven meta-analyses. The research underscores the beneficial effects of flavonoids in the management of NAFLD through the enhancement of lipid metabolism, the reduction in hepatic steatosis, and the provision of anti-inflammatory actions. Clinical trials demonstrate that interventions rich in flavonoids, including quercetin, epigallocatechin gallate, naringenin, and isoflavones, substantially reduce liver fat content and enhance liver enzyme profiles, with certain compounds exhibiting superior efficacy in particular subgroups, such as older adults and females. Nonetheless, whereas these therapies significantly diminish hepatic steatosis, their effect on fibrosis is constrained. To sum up, flavonoids exhibit significant potential as supplementary treatments for NAFLD by enhancing liver function, lipid metabolism, and inflammation. Additional extensive controlled clinical trials are necessary to create uniform treatment methods and ascertain their long-term therapeutic advantages. Full article

Agrobacterium-mediated transformation is a widely used method for plant genetic modification. However, its efficiency in tea plants is notably low, and the underlying molecular mechanisms remain unclear, hindering advancements in the molecular breeding and biology of tea plants. In this study, tobacco was utilized as a model to investigate the effects of various concentrations of epigallocatechin-3-gallate (EGCG) on Agrobacterium transformation efficiency. The results demonstrated that at an EGCG concentration of 0.4 mg/mL, Agrobacterium nearly lost its ability to transform tobacco. Additionally, malondialdehyde content in Agrobacterium was measured before and after EGCG treatment. The findings indicated that EGCG treatment led to an increase in malondialdehyde content. Transcriptome sequencing analysis revealed that differentially expressed genes (DEGs) involved in Agrobacterium flagellar synthesis and secretion systems were down-regulated under EGCG stress. Furthermore, flgE, virB4, and virB6 were identified as hub genes through weighted gene co-expression network analysis (WGCNA). These results elucidate the dynamic mechanisms by which EGCG affects Agrobacterium at both the physicochemical and molecular levels, providing a theoretical basis for optimizing genetic transformation in tea plants. Full article

Cosmetic products contain numerous metals used as pigments, UV filters, preservatives, antiperspirants and antimicrobial agents, which are responsible for allergic skin reactions, with the most common being nickel. To reduce skin penetration of Ni, innovative pharmaceutical formulations such as lipogels with chelating action against the metal ions themselves can be used. Chelation therapy allows a chelating agent to combine with metal ions to form a stable ring structure called a chelate. The chelate structure is more soluble in water than the toxic metal, which facilitates removal of the toxic metal from the tissue and its excretion by the kidneys. The aim of the following work was to evaluate the chelating properties against nickel ions of different types of lipogels containing flavonoids such as resveratrol and epigallocatechin gallate with chelating activities largely dependent on the number and position of their hydroxyl groups. The results obtained showed that lipogels based on epigallocatechin gallate show high chelating action against nickel, especially at low concentrations. In addition, rheological studies showed an ideal profile to ensure viscoelasticity and swelling of the lipogel within 48 h, confirming reports of 75% epigallocatechin release from the lipogel after 48 h. Tests have shown that lipogels based on epigallocatechin gallate have high chelating action against nickel, especially at low concentrations. Full article

Background: Cuproptosis is a form of copper-dependent non-apoptotic cell death. Cancer cells that prefer to use aerobic glycolysis for energy generation are commonly insensitive to cuproptosis, which hinders its application for cancer treatment. Epigallocatechin gallate (EGCG) possesses diverse pharmacological activities. However, the association between EGCG and cuproptosis has not been studied. Methods: The cell viability, proliferation, and cuproptosis-related protein levels were detected to investigate whether EGCG enhances the sensitivity of HCC cells to cuproptosis. The intracellular copper level, related copper metabolism proteins, and gene expression were detected to explore the mechanisms. In addition, a nude mouse xenograft model was established to determine the effects of EGCG on cuproptosis in tumor tissues. Results: The combination of EGCG and copper ionophores significantly enhanced the mortality of HCC cells and heightened the sensitivity of HCC cells to cuproptosis. There was a notable reduction in the expression of copper export protein copper-transporting P-type ATPase (ATP7B). EGCG effectively suppressed metal regulatory transcription factor (MTF1) expression and subsequently hindered the transcriptional regulation of ATP7B. EGCG also facilitated the intratumoral accumulation of copper and augmented susceptibility to cuproptosis in vivo. Conclusions: EGCG can increase the sensitivity of hepatocellular carcinoma cells to cuproptosis by promoting intracellular copper accumulation through the MTF1/ATP7B axis. Full article

Intestinal inflammation significantly compromises broiler health and adversely affects growth performance. Epigallocatechin gallate (EGCG) was found to maintain the gut health of animals. However, the role and mechanism of EGCG in preventing lipopolysaccharide (LPS)-induced intestinal inflammation in chicks have not yet been fully elucidated. In the 35-day study, 140 one-day-old Wenchang chickens were randomly assigned to four treatments: CON (basal diet), LPS (basal diet + 1 mg/kg body weight (BW) LPS), L-EGCG (basal diet + 40 mg/kg BW EGCG + 1 mg/kg BW LPS), and H-EGCG (basal diet + 60 mg/kg BW EGCG + 1 mg/kg BW LPS). On days 31, 33, and 35 of age, broilers in the LPS, L-EGCG, and H-EGCG treatments received intraperitoneal injections of LPS. The LPS reduced jejunal villus height, villus height/crypt depth ratio, Claudin1 mRNA, catalase (CAT) activity, and interleukin-10 (IL-10) levels compared to CON while elevating diamine oxidase (DAO), interleukin-1β (IL-1β), and tumor necrosis factor α (TNF-α). EGCG improved growth performance in LPS-challenged broilers, elevating jejunal villus height and Claudin1/ZO-1 mRNA with reduced serum DAO. It enhanced antioxidant capacity via increased serum total antioxidant capacity (T-AOC), total superoxide dismutase (T-SOD), CAT, glutathione peroxidase (GSH-Px) activities, and a decreased malondialdehyde (MDA) concentration. Concurrently, EGCG lowered IL-1β/TNF-α and raised IL-10 in serum/jejunum. Crucially, EGCG suppressed jejunal TLR4/MyD88/NF-κB mRNA and protein expression under LPS. These findings demonstrate EGCG’s protective role against LPS-induced intestinal inflammation in Wenchang chickens through TLR4/MyD88/NF-κB pathway inhibition. Full article

Type 2 diabetes is usually accompanied by premature grey hair. In this study, we analysed differences in the lipid composition of black and white hair follicles between women with type 2 diabetes and healthy populations, using lipidomic methods. We examined the correlation between the lipid composition of female grey hair follicles and type 2 diabetes mellitus, and we screened for potential grey-hair-delaying ingredients using network pharmacology. Forty-one female volunteers with type 2 diabetes (diabetes, D) and thirty-five healthy volunteers (healthy, H) aged 55–65 years were recruited. Hair roots, including the follicular portion, were collected from grey hair (D-W for diabetic volunteers and H-W for healthy volunteers) and black hair (D-B for diabetic volunteers and H-B for healthy volunteer). Lipids were extracted separately and analysed using UPLC-QTOF-MS (Ultra-Performance Liquid Chromatography–Tandem Time-of-Flight Mass Spectrometry), combined with an OPLS-DA (Orthogonal Partial Least Squares Discriminant Analysis) model to identify different lipids among different groups under VIP conditions (VIP > 1, p < 0.05, and fold change ≥ 2). Further screening was performed using the ROC (receiver operating characteristic) curve method, selecting lipids with an AUC (area under the curve) value greater than 0.8 and specificity plus sensitivity greater than 1.6. Finally, bioinformatics and reverse network pharmacology were used to screen relevant targets, ingredients, and herbs to find suitable raw materials with anti-grey-hair effects. We found the following: (1) Ten significant differential lipids were identified under VIP conditions in the D-W and D-B groups, and five potential differential lipids (1-O-alpha-D-glucopyranosyl-1,2-eicosandiol, emmotin A, odyssic acid, PI-Cer(t18:0/26:0(2OH)), and NAPE(18:1(9Z)/16:1(9Z)/18:0)) were further screened using ROC analysis. The levels of all five lipids were significantly higher in D-W than in D-B, and these elevated levels may have been related to the production of grey hair in diabetic patients. (2) Thirteen significantly different lipids were screened under VIP conditions in the H-W and H-B groups, and five potential differential lipids were screened via ROC analysis (PS(O-16:0/13:0), PA(12:0/16:1(9Z)), PS(13:0/20:3(8Z,11Z,14Z)), GlcCer(d18:1/24:1(15Z)), and PS(O-20:0/17:2(9Z,12Z))). The levels of all five lipids were significantly higher in H-B than in H-W, and we hypothesised that their reduced levels were associated with the production of grey hair in the healthy population. (3) Twelve significantly different lipids were screened under VIP conditions in the D-W and H-W groups, and two potential differential lipids were screened via ROC analysis (fucoxanthinol 3-heptadecanoate 3′-myristate and 2-(3-hydroxyphytanyl)-3-phytanyl-sn-glycerol). The contents of both lipids were significantly higher in H-W than in D-W, and there were differences in the lipid composition of grey hair in the D and H populations. (4) Important ingredients with possible therapeutic effects were obtained through lipid-matched target screening: resveratrol, calycosin, epigallocatechin 3-gallate, and herbs such as the fruit of the glossy privet, etc. In summary, the production of grey hair in the D and H populations may be affected by different lipids. The lipid components emmotin A and fucoxanthinol 3-heptadecanoate 3′-myristate were significantly higher in the D and H populations than in the same groups (D-B, H-B), and these are pregnenolone lipids (PRs). We hypothesised that PRs can influence the production of grey hair in both populations. The screening of important differential lipids may serve to provide diagnostic loci or therapeutic targets, while matching ingredients and herbs may provide a basis and direction for the subsequent development of anti-grey-hair ingredients. Full article